-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 PNSQSu535gxqPLFVvpfag0XN4Bjx5CM9FqAB3s5y2z8A0gi8z7X9RIvyfAbgQZUi
 RJPjza3orQh1Mn/wNkiPvA==

<SEC-DOCUMENT>0001396677-10-000003.txt : 20100108
<SEC-HEADER>0001396677-10-000003.hdr.sgml : 20100108
<ACCEPTANCE-DATETIME>20100108160728
ACCESSION NUMBER:		0001396677-10-000003
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20100107
FILED AS OF DATE:		20100108
DATE AS OF CHANGE:		20100108

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Seelos Andrew W
		CENTRAL INDEX KEY:			0001396677

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23731
		FILM NUMBER:		10517822

	MAIL ADDRESS:	
		STREET 1:		C/O NUTRACEUTICAL CORPORATION
		STREET 2:		1400 KEARNS BOULEVARD, 2ND FLOOR
		CITY:			PARK CITY
		STATE:			X1
		ZIP:			84060

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NUTRACEUTICAL INTERNATIONAL CORP
		CENTRAL INDEX KEY:			0001050007
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870515089
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		1400 KEARNS BOULEVARD
		STREET 2:		2ND FLOOR
		CITY:			PARK CITY
		STATE:			UT
		ZIP:			84060
		BUSINESS PHONE:		4356556000

	MAIL ADDRESS:	
		STREET 1:		1400 KEARNS BOULEVARD
		STREET 2:		2ND FLOOR
		CITY:			PARK CITY
		STATE:			UT
		ZIP:			84060
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2010-01-07</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001050007</issuerCik>
        <issuerName>NUTRACEUTICAL INTERNATIONAL CORP</issuerName>
        <issuerTradingSymbol>NUTR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001396677</rptOwnerCik>
            <rptOwnerName>Seelos Andrew W</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O NUTRACEUTICAL CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>1400 KEARNS BOULEVARD, 2ND FLOOR</rptOwnerStreet2>
            <rptOwnerCity>PARK CITY</rptOwnerCity>
            <rptOwnerState>X1</rptOwnerState>
            <rptOwnerZipCode>84060</rptOwnerZipCode>
            <rptOwnerStateDescription>UNITED STATES</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Asst VP &amp; Controller</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2010-01-07</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>163.599</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>12.225</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>10189.685</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The purchase reported in this Form 4 was effected pursuant to an enrollment plan under the issuer's Stock Purchase Plan for Employees, Stakeholders and Shareholders adopted by the reporting person on March 20, 2008.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Alison Pitt, attorney in fact</signatureName>
        <signatureDate>2010-01-08</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----